Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: A double-blind, randomized, controlled trial - Wynne, K; Park, A J; Small, C J; Patterson, M; Ellis, S M; Murphy, K G; Wren, A M; Frost, G S; Meeran, K; Ghatei, M A; Bloom, S R (Diabetes, 2005)